» Articles » PMID: 10987275

Fibrinogen E-fragment Inhibits the Migration and Tubule Formation of Human Dermal Microvascular Endothelial Cells in Vitro

Overview
Journal Cancer Res
Specialty Oncology
Date 2000 Sep 15
PMID 10987275
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Angiogenesis, the development of new blood vessels from an existing vascular bed, is essential for the growth and spread of malignant tumors. Several endogenous angiogenesis inhibitors have been discovered and shown to suppress endothelial cell function in vitro and tumor growth in vivo. Several of these are proteolytic fragments of larger, endogenous proteins. Here we show that a Mr 50,000 polypeptide derived from the plasmin cleavage of fibrinogen, fibrinogen E-fragment, inhibits endothelial cell migration and tubule formation induced by both proangiogenic growth factors, vascular endothelial growth factor and basic fibroblast growth factor, in vitro.

Citing Articles

A new hemostatic agent composed of Zn-enriched Ca alginate activates vascular endothelial cells and promotes tissue repair .

Ponsen A, Proust R, Soave S, Mercier-Nome F, Garcin I, Combettes L Bioact Mater. 2022; 18:368-382.

PMID: 35415309 PMC: 8965972. DOI: 10.1016/j.bioactmat.2022.01.049.


Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent and retards B16-F10 melanoma growth in a preclinical model.

Ferreira A, Cristofaro B, Menezes M, Oliveira A, Tashima A, de Melo R Oncotarget. 2021; 11(51):4770-4787.

PMID: 33473260 PMC: 7771711. DOI: 10.18632/oncotarget.27839.


Customizable 3D-Printed (Co-)Cultivation Systems for In Vitro Study of Angiogenesis.

Siller I, Epping N, Lavrentieva A, Scheper T, Bahnemann J Materials (Basel). 2020; 13(19).

PMID: 32992945 PMC: 7579111. DOI: 10.3390/ma13194290.


Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis.

Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang L Cancer Sci. 2015; 106(11):1596-606.

PMID: 26300396 PMC: 4714678. DOI: 10.1111/cas.12797.


The Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery Disease.

Fu G, Hu M, Chu L, Zhang M Int J Endocrinol. 2015; 2015:758402.

PMID: 26089891 PMC: 4451558. DOI: 10.1155/2015/758402.